Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2)

Navigation

Article	Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2)
Sections in this Publication
Section	Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2)
Section	Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2)
Section	Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2)
Section	Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2)
Section	Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2)
Section	Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2)
Section	Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2)
Section	Conflict of Interest (from DOI: 10.1007/s11886-020-01293-2)
Section	References (from DOI: 10.1007/s11886-020-01293-2)
Named Entities in this Section
Entity	Cardiovascular Diseases (disease - MeSH descriptor)
Entity	Cardiomyopathies (disease - MeSH descriptor)
Entity	Arrhythmias, Cardiac (disease - MeSH descriptor)
Entity	Cardiac Complexes, Premature (disease - MeSH descriptor)
Entity	Human (species)
Entity	COVID-19 (disease - MeSH supplementary concept)
Entity	Cardiac Death (disease - MeSH descriptor)
Entity	Respiratory Insufficiency (disease - MeSH descriptor)
Entity	Heart Failure (disease - MeSH descriptor)
Entity	Heart Disease (disease - MeSH descriptor)
Dataset	Pubtator Central BioC-JSON formatted article files

From publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" published as Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34. DOI: https://doi.org/10.1007/s11886-020-01293-2

Section 3.1: Cardiac Complications of COVID-19

Initial reports from Wuhan noted a significant association of the presence of cardiac complications with overall mortality in COVID-19 patients. Notably, Ruan Q et al. showed that among those who died due to COVID-19, the cause of death was respiratory failure and myocardial injury in 33% (22/68) of the patients and primary myocardial injury and/or heart failure in 7% of the patients. These observations were further corroborated in a study by Shi et al. who showed higher rates of ventilator requirement and in-hospital mortality in those with cardiac injury. In their Cox regression model, patients with cardiac injury were at a higher risk of death throughout the disease course compared to those without. Given these observations, much focus has been placed on better understanding cardiovascular sequelae of COVID19. The observed cardiovascular complications associated with COVID-19 can be roughly characterized into 1: myocardial injury and heart failure 2: arrhythmias.